Search

Author/Creator Ladda, Ekkehart

1. Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2). (October 2021)

Authors:
Möbus, Volker; Lück, Hans-Joachim; Ladda, Ekkehart; Klare, Peter; Schmidt, Marcus; Schneeweiss, Andreas; Grischke, Eva-Maria; Wachsmann, Grischa; Forstbauer, Helmut; Untch, Michael; Marmé, Frederik; Blohmer, Jens-Uwe; Jackisch, Christian; Huober, Jens; Stickeler, Elmar; Reinisch, Mattea; Link, Th...
Journal:
European journal of cancer
Issue:
Volume 156(2021)
Page Start:
138
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 study. (December 2022)

Authors:
Reinisch, Mattea; Untch, Michael; Mahlberg, Rolf; Reimer, Toralf; Hitschold, Thomas; Marmé, Frederik; Aydogdu, Mustafa; Schmatloch, Sabine; Lück, Hans-Joachim; Schmidt, Marcus; Ladda, Ekkehart; Sinn, Bruno Valentin; Klare, Peter; Janni, Wolfgang; Jackisch, Christian; Denkert, Carsten; Seiler, Sab...
Journal:
Breast
Issue:
Volume 66(2022)
Page Start:
110
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search